CRONOS GROUP INC. Stock-Based Compensation
CRONOS GROUP INC. (CRON) reported Stock-Based Compensation of $2.87 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- CRONOS GROUP INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $1.56M, a 12.74% increase year-over-year.
- CRONOS GROUP INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.31M, a 37.12% decline year-over-year.
- CRONOS GROUP INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.25M, a 42.94% decline year-over-year.
- CRONOS GROUP INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.33M, a 3.14% increase year-over-year.
- CRONOS GROUP INC. share-based payment arrangement, noncash expense for fiscal 2025 was $7.05M, a 18.97% decline from fiscal 2024.
- CRONOS GROUP INC. share-based payment arrangement, noncash expense for fiscal 2024 was $8.70M, a 0.79% decline from fiscal 2023.
- CRONOS GROUP INC. share-based payment arrangement, noncash expense for fiscal 2023 was $8.77M, a 41.98% decline from fiscal 2022.
- CRONOS GROUP INC. share-based payment arrangement, noncash expense for fiscal 2022 was $15.12M, a 48.90% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.87M 10-Q · filed 2026-08-06 | $4.12M derived: sum of 3 quarters · filed 2026-08-06 | $6.45M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.31M 10-Q · filed 2026-05-11 | $2.56M derived: sum of 2 quarters · filed 2026-05-11 | $4.89M derived: sum of 3 quarters · filed 2026-05-11 | $6.28M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.58M derived: sum of 2 quarters · filed 2026-02-26 | $4.96M derived: sum of 3 quarters · filed 2026-08-06 | $7.05M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.71M derived: sum of 2 quarters · filed 2026-08-06 | $5.80M 10-Q · filed 2025-11-06 | $7.99M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.47M 10-Q · filed 2026-08-06 | $5.66M derived: sum of 3 quarters · filed 2026-08-06 | $7.92M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $2.09M 10-Q · filed 2026-05-11 | $4.28M derived: sum of 2 quarters · filed 2026-05-11 | $6.54M derived: sum of 3 quarters · filed 2026-05-11 | $8.77M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.45M derived: sum of 2 quarters · filed 2026-02-26 | $6.68M derived: sum of 3 quarters · filed 2026-02-26 | $8.70M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $4.50M derived: sum of 2 quarters · filed 2025-11-06 | $6.51M 10-Q · filed 2025-11-06 | $8.44M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $2.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $4.25M 10-Q · filed 2025-08-07 | $6.18M derived: sum of 3 quarters · filed 2026-02-26 | $8.13M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $2.02M 10-Q · filed 2025-05-08 | $3.94M derived: sum of 2 quarters · filed 2026-02-26 | $5.90M derived: sum of 3 quarters · filed 2026-02-26 | $8.23M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.88M derived: sum of 2 quarters · filed 2026-02-26 | $6.22M derived: sum of 3 quarters · filed 2026-02-26 | $8.77M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $4.29M derived: sum of 2 quarters · filed 2024-11-12 | $6.84M 10-Q · filed 2024-11-12 | $11.39M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $2.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $4.89M 10-Q · filed 2024-08-08 | $9.44M derived: sum of 3 quarters · filed 2025-02-27 | $13.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $2.55M 10-Q · filed 2024-05-09 | $7.10M derived: sum of 2 quarters · filed 2025-02-27 | $11.36M derived: sum of 3 quarters · filed 2025-02-27 | $13.98M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $4.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $8.81M derived: sum of 2 quarters · filed 2025-02-27 | $11.43M derived: sum of 3 quarters · filed 2025-02-27 | $15.12M 10-K · filed 2025-02-27 |
| 2022-09-30 | $4.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $6.88M derived: sum of 2 quarters · filed 2023-11-08 | $10.57M 10-Q · filed 2023-11-08 | $12.99M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $6.30M 10-Q · filed 2023-08-08 | $8.72M derived: sum of 3 quarters · filed 2024-02-29 | $11.39M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $3.69M 10-Q · filed 2023-05-09 | $6.11M derived: sum of 2 quarters · filed 2024-02-29 | $8.77M derived: sum of 3 quarters · filed 2024-02-29 | $11.34M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $5.09M derived: sum of 2 quarters · filed 2024-02-29 | $7.65M derived: sum of 3 quarters · filed 2024-02-29 | $10.15M 10-K · filed 2024-02-29 |
| 2021-09-30 | $2.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $5.23M derived: sum of 2 quarters · filed 2022-11-07 | $7.73M 10-Q · filed 2022-11-07 | $10.19M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $5.06M 10-Q · filed 2022-08-09 | $7.53M derived: sum of 3 quarters · filed 2023-02-28 | $15.44M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $2.50M 10-Q · filed 2022-05-10 | $4.96M derived: sum of 2 quarters · filed 2023-02-28 | $12.88M derived: sum of 3 quarters · filed 2023-02-28 | $15.42M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $10.38M derived: sum of 2 quarters · filed 2023-02-28 | $12.93M derived: sum of 3 quarters · filed 2023-02-28 | $15.36M 10-K · filed 2023-02-28 |
| 2020-09-30 | $7.92M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-02-18 | $10.46M derived: sum of 2 quarters · filed 2022-02-18 | $12.90M 10-Q · filed 2022-02-18 | $16.57M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $2.55M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-02-18 | $4.98M 10-Q/A · filed 2022-02-18 | $8.65M derived: sum of 3 quarters · filed 2022-03-01 | $12.18M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $2.44M 10-Q · filed 2021-05-07 | $6.11M derived: sum of 2 quarters · filed 2022-03-01 | $9.64M derived: sum of 3 quarters · filed 2022-03-01 | $12.28M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $7.20M derived: sum of 2 quarters · filed 2022-03-01 | $9.85M derived: sum of 3 quarters · filed 2022-03-01 | $11.62M 10-K · filed 2022-03-01 |
| 2019-09-30 | $3.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $6.18M derived: sum of 2 quarters · filed 2020-11-05 | $7.95M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $2.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $4.42M 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $1.77M 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | $8.15M 10-K · filed 2021-02-26 | |||
| 2017-12-31 | $1.93M 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |